Sandoz Antitrust Claims Nixed In Bayer's Yaz IP Suits
A federal judge has dismissed antitrust counterclaims filed by Sandoz Inc. in two Bayer Schera Pharma AG lawsuits accusing the generics maker of infringing patents for oral contraceptive drugs Yasmin and...To view the full article, register now.
Already a subscriber? Click here to view full article